Results 181 to 190 of about 50,167 (231)

Outcomes of tofacitinib dose reduction in patients with ulcerative colitis in stable remission: a long-term follow-up of the randomized RIVETING trial. [PDF]

Crohns Colitis 360
Rubin DT, Panés J, Torres J, Kobayashi T, Su C, Lawendy N, Modesto I, Segovia M, Gardiner S, Wang W, Vermeire S.   +10 more
europepmc   +1 more source

Tofacitinib for Calcinosis Cutis Associated With Juvenile Dermatomyositis: An Open-Label Single-Arm Study. [PDF]

ACR Open Rheumatol
Jain P, Mohan SL, Kaushik S, Deepak R, Mishra D, Khan MA, Gupta V, Naranje P, Ramanan AV, Lodha R, Jana M, Bagri NK.   +11 more
europepmc   +1 more source

JAK Inhibitor Tofacitinib Ameliorates Inflammation Response and Osteogenic Differentiation in Immune-Mediated Inflammatory Arthritis in Rats. [PDF]

Int J Rheum Dis
Zhang Z, Lin Z, Hu G, Huang Q, Xu C, Zhang J, Wu F, Song R, Chen H, Zheng F.   +9 more
europepmc   +1 more source

Rapid and Successful Treatment of Interstitial Granulomatous Dermatitis With Tofacitinib: A Case Report. [PDF]

Clin Case Rep
Farmani A, Saber M.
europepmc   +1 more source

A protracted diagnostic journey of pediatric PAPA syndrome and subsequent response to tofacitinib therapy: a case report and literature review. [PDF]

Front Immunol
He S, Deng H, Yang J, Jiang W.
europepmc   +1 more source

Tofacitinib as Rescue Therapy in Steroid-Refractory Acute Severe Ulcerative Colitis: A Retrospective Cohort Study with Observations on Cytomegalovirus Coinfection. [PDF]

Cureus
Banerjee S, Yadav D, Gupta A, Kumar U, Shukla S, Kumar V, Tiwari AK, Kumar VM, Singla A, Patel NK.   +9 more
europepmc   +1 more source

Influence of Ageing on the Pharmacology, Efficacy and Safety of Oral Targeted Therapies for Inflammatory Bowel Disease: Focus on Janus Kinase (JAK) Inhibitors and Sphingosine-1-Phosphate (S1P) Receptor Modulators. [PDF]

Drugs Aging
Derijks LJJ, Karapinar-Çarkit F, Mujagić Z, van Marum RJ, Pierik MJ.   +4 more
europepmc   +1 more source

Oral Tofacitinib versus Azathioprine in the Management of Chronic Actinic Dermatitis - An Open Randomized Clinical Trial. [PDF]

Indian Dermatol Online J
Singhal R, Hussain AA, Jamale VP, Nikam BP, Sharma PA.   +4 more
europepmc   +1 more source

JAK Inhibitors in Colchicine Resistant FMF Patients: A Case-Based Review. [PDF]

Mediterr J Rheumatol
Salehzadeh F, Molatefi R, Khoei FB.
europepmc   +1 more source